ATLASLifecore Biomedical (LFCR) earnings date: expected December 16–22
Lifecore Biomedical (LFCR) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around December 16–22. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on LFCR
| Last price | $6.39 (-0.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.6% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Lifecore Biomedical stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around December 16–22 (estimate). One email the day before, with ATLAS’s read on Lifecore Biomedical. You can switch it off at any time.
Alert me before LFCR reportsFree to start. Creating an account takes under a minute.
Notify me when Lifecore Biomedical reports
Track LFCR free Add Lifecore Biomedical to a free ATLAS watchlist and see its next report date in one place.
LFCR earnings at a glance
| Next report | Not announced · expected around December 16–22 (ATLAS estimate) |
|---|---|
| Last report | Aug 5, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -3.0% |
| Average move around a report | ±13.6% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
The expected window is an ATLAS estimate: it takes the typical gap between Lifecore Biomedical’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Lifecore Biomedical earnings history: last 5 reports
Lifecore Biomedical last reported on Aug 5, 2026: EPS of -$0.19 against an estimate of -$0.22 (+13.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | -$0.22 | -$0.19 | +13.6% | Beat | +11.3% |
| May 6, 2026 | -$0.29 | -$0.43 | -48.3% | Miss | -7.6% |
| Apr 8, 2026 | $0.35 | $0.57 | +62.9% | Beat | +14.8% |
| Mar 16, 2026 | -$0.16 | -$0.16 | 0.0% | In line | -33.3% |
| Nov 6, 2025 | -$0.30 | -$0.43 | -43.3% | Miss | +1.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for LFCR
See the fair value, the probability range and the earnings history of Lifecore Biomedical on its ATLAS page.
Lifecore Biomedical (LFCR) stock analysisPlans from €3.99 a month.
Lifecore Biomedical earnings: frequently asked questions
When is Lifecore Biomedical (LFCR) next earnings date?
Lifecore Biomedical has not announced its next report. Its last 3 reports came Aug 5, 2026, May 6, 2026, Nov 6, 2025, so ATLAS estimates the next one around December 16–22. This is an estimate based on that pattern, not a confirmed date.
How often does LFCR beat earnings estimates?
Of its last 5 reports with a recorded result, Lifecore Biomedical beat the EPS estimate 2 times; the average surprise was -3.0%. Past results do not predict the next one.
How much does LFCR move around earnings?
Over its last 5 reports the stock moved an average of 13.6% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Lifecore Biomedical beat earnings estimates last quarter?
Lifecore Biomedical last reported on Aug 5, 2026: EPS of -$0.19 against an estimate of -$0.22 (+13.6% surprise), a beat.
How much does LFCR usually move in a day?
On a normal trading day the ATLAS model puts LFCR’s one-day range at about ±4.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer